Immediate Impact
9 standout
Citing Papers
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
2024 Standout
Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Works of Fangzhou Ye being referenced
Individualized risk prediction of significant fibrosis in non‐alcoholic fatty liver disease using a novel nomogram
2019
Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Fangzhou Ye | 147 | 122 | 23 | 91 | 21 | 291 | |
| Johan Swinnen | 125 | 105 | 20 | 96 | 14 | 313 | |
| Yirui Yin | 199 | 131 | 24 | 81 | 20 | 328 | |
| Yuchen Hou | 179 | 101 | 22 | 71 | 19 | 297 | |
| Sampa Ghose | 182 | 98 | 22 | 51 | 20 | 330 | |
| Ankit Patel | 98 | 70 | 15 | 76 | 26 | 277 | |
| Xiaoguang Liu | 114 | 92 | 23 | 70 | 17 | 228 | |
| Xiaoyong Cai | 218 | 231 | 44 | 71 | 24 | 331 | |
| Lijuan Bian | 150 | 126 | 43 | 38 | 18 | 297 | |
| Estelle Daudigeos‐Dubus | 160 | 71 | 10 | 88 | 18 | 326 | |
| Xianguo Zhou | 234 | 155 | 26 | 89 | 22 | 331 |
All Works
Login with ORCID to disown or claim papers
Loading papers...